Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

Related Articles by Review for PubMed (Select 15349707)

2.

[New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].

de Korwin JD, Ducrotté P, Vallot T.

Presse Med. 2004 Jun 19;33(11):746-54. Review. French.

PMID:
15257232
3.

[All proton pump inhibitors are equally efficacious in standard dosages].

Hellström PM, Vitols S.

Lakartidningen. 2003 Jun 19;100(25):2212-6. Review. Swedish.

PMID:
12872509
4.
5.

Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management.

Orr WC.

Eur J Gastroenterol Hepatol. 2005 Jan;17(1):113-20. Review.

PMID:
15647651
6.

Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders.

Robinson M.

Aliment Pharmacol Ther. 2004 Nov;20 Suppl 6:30-7. Review.

PMID:
15496216
7.

Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

Welage LS, Berardi RR.

J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. Review.

PMID:
10665250
8.

Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.

Freston JW.

Am J Med. 2004 Sep 6;117 Suppl 5A:14S-22S. Review.

PMID:
15478848
9.
10.

Review article: gastric acidity--comparison of esomeprazole with other proton pump inhibitors.

Hatlebakk JG.

Aliment Pharmacol Ther. 2003 Feb;17 Suppl 1:10-5; discussion 16-7. Review.

PMID:
12614300
11.

What is potent acid inhibition, and how can it be achieved?

Calvet X, Gomollón F.

Drugs. 2005;65 Suppl 1:13-23. Review.

PMID:
16335854
12.

The proton-pump inhibitors: similarities and differences.

Horn J.

Clin Ther. 2000 Mar;22(3):266-80; discussion 265. Review.

PMID:
10963283
13.

Stereoselective disposition of proton pump inhibitors.

Andersson T, Weidolf L.

Clin Drug Investig. 2008;28(5):263-79. Review.

PMID:
18407713
14.

Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.

Kromer W, Horbach S, Lühmann R.

Pharmacology. 1999 Aug;59(2):57-77. Review.

PMID:
10450061
15.

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Andersson T.

Clin Pharmacokinet. 1996 Jul;31(1):9-28. Review. Erratum in: Clin Pharmacokinet 1996 Oct;31(4):274.

PMID:
8827397
16.

Pantoprazole: from drug metabolism to clinical relevance.

Bardou M, Martin J.

Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):471-83. doi: 10.1517/17425255.4.4.471 . Review.

PMID:
18433349
17.

An overview of proton pump inhibitors.

Der G.

Gastroenterol Nurs. 2003 Sep-Oct;26(5):182-90. Review.

PMID:
14603076
18.

Intravenous proton pump inhibitors.

Baker DE.

Rev Gastroenterol Disord. 2006 Winter;6(1):22-34. Review.

PMID:
16520709
19.

Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans.

Londong W.

Aliment Pharmacol Ther. 1994;8 Suppl 1:39-46. Review.

PMID:
8180293
20.

Synthesis or rupture: duration of acid inhibition by proton pump inhibitors.

Sachs G, Shin JM, Pratha V, Hogan D.

Drugs Today (Barc). 2003 Mar;39 Suppl A:11-4. Review.

PMID:
12712216
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk